Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda

Author:

Baldeh Ayo-Oley,Millard ColinORCID,Pollock Allyson M.,Brhlikova Petra

Abstract

Abstract Background Essential medicines (EMs) are those that satisfy the basic healthcare needs of the population. However, access to EMs remains a global health challenge. The World Health Organization (WHO) and the East African Community (EAC) manufacturing plan 2017–2027 support local production of EMs as a strategy to improve access to medicines. The aim of this study was to determine for each therapeutic class on the national essential medicine lists (NEMLs) of Kenya, Tanzania and Uganda, the number of EMs produced in each country. Methods In 2018, we analysed NEMLs and national drug registers (NDRs) in each country to identify local manufacturers and local products by EM status. For each local manufacturer we determined the number of EM products and individual EMs, and analysed EMs in each therapeutic class by registration status and whether produced locally. Results There were nine companies manufacturing locally in Kenya, four in Tanzania and six in Uganda. Most local medicine products were non-EM products. Of the 946 locally produced products in Kenya, 310 were EM products; of the 97 locally produced products in Tanzania, 39 were EM products; and of the 181 locally produced products in Uganda, 100 were EM products. Many local EM products were duplicate. Only a small proportion of EMs on each NEML were produced locally: 21% (92/430) in Kenya, 5% (24/510) in Tanzania, and 10% (55/526) in Uganda. Kenya, Tanzania and Uganda had no local EM products in 13/32, 17/28 and 15/32 therapeutic classes, respectively. The proportion of EMs that were registered varied across the countries from 327 (76%) in Kenya, 269 (53%) in Tanzania, and 319 (60%) in Uganda. Conclusions This study highlights the importance of auditing NDRs and NEMLs for local production to inform regional and national local manufacturing strategies. EMs should be prioritized for local production and drug registration to ensure that production is aligned with local health needs.

Publisher

Informa UK Limited

Subject

Pharmacy,Health Policy

Reference25 articles.

1. Chan M. Ten years in public health. [Online]. 2017. https://apps.who.int/iris/bitstream/handle/10665/255355/9789241512442-eng.pdf?sequence=1. Accessed 13th Dec 2019.

2. World Health Organization. Interagency statement on promoting local production of medicines and other health technologies. [Online]. https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2019/may/20190524_local-production-medicines. Accessed 13th Jan 2020.

3. World Health Organization. Local production and access to medicines in Low-and middle-income countries A literature review and critical analysis. [Online]. 2011. https://medeor.de/images/themen/konferenz/Local_Production_Literature_Review.pdf. Accessed 25th Nov 2019.

4. Kaplan WA, Ritz LS, Vitello M. Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literature. Southern Med Review. 2011;4(2):4–14. https://doi.org/10.5655/smr.v4i2.1002.

5. World Health Organization. Local production for access to medical products: developing a framework to improve public health. [Online]. 2011. https://www.who.int/phi/publications/Local_Production_Policy_Framework.pdf. Accessed 13th Jan 2020.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3